Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a tyrosine kinase inhibitor medication for the treatment of chronic immune thrombocytopenia (ITP). [2] [3] The drug is administered by mouth. [2] [3] Fostamatinib blocks the activity of the enzyme spleen tyrosine kinase (SYK). [3]

2024年10月14日 · Fostamatinib is used to treat chronic immune thrombocytopenia, a bleeding condition caused by a lack of platelets in the blood. fostamatinib is given after other treatments have failed. Fostamatinib may also be used for purposes not listed in this medication guide.

2024年12月9日 · Tavalisse (fostamatinib), from Rigel Pharmaceuticals, is an oral spleen tyrosine kinase (SYK) inhibitor. In ITP, the immune system attacks and destroys the body's own blood platelets which help with blood clotting and healing.

On April 17, 2018, the Food and Drug Administration approved fostamatinib disodium hexahydrate tablets (TAVALISSE, Rigel Pharmaceuticals, Inc.) for the treatment of thrombocytopenia in adult...

Find patient medical information for fostamatinib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.

TAVALISSE is a spleen tyrosine kinase (SYK) inhibitor indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Protecting platelets. defending patients. References: 1.